日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma

多价阿特珠单抗-脂质体偶联物作为增强黑色素瘤PD-L1阻断的活性免疫治疗平台

Cheng, Ziyun; Amin, Mohamadreza; van Brakel, Mandy; Sacchetti, Andrea; Kim, Robbert Q; Seynhaeve, Ann L B; Debets, Reno; Ten Hagen, Timo L M

CXCL10 Secreted by Pericytes Mediates TNFα-Induced Vascular Leakage in Tumors and Enhances Extravasation of Nanoparticle-Based Chemotherapeutics.

周细胞分泌的 CXCL10 介导 TNFα 诱导的肿瘤血管渗漏,并增强纳米颗粒化疗药物的外渗

Seynhaeve Ann L B, Liu Hui, Priester Marjolein I, Valentijn Mike, van Holten-Neelen Conny, Brouwer Rutger W W, van Brakel Mandy, Dik Willem A, van IJcken Wilfred F J, Debets Reno, Stubbs Andrew P, Ten Hagen Timo L M

A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer

一种用于检测转移性尿路上皮癌患者对帕博利珠单抗耐药性的血液免疫标志物

Rijnders, Maud; Robbrecht, Debbie G J; Oostvogels, Astrid A M; van Brakel, Mandy; Boormans, Joost L; Aarts, Maureen J B; Balcioglu, Hayri E; Hamberg, Paul; Voortman, Jens; Westgeest, Hans M; Lolkema, Martijn P; de Wit, Ronald; van der Veldt, Astrid A M; Debets, Reno

Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy

利用基因工程改造T细胞,使其表达T细胞受体,用于过继疗法

Kortleve, Dian; van Brakel, Mandy; Wijers, Rebecca; Debets, Reno; Hammerl, Dora

Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer

基于血液的激酶活性谱分析:转移性癌症免疫检查点抑制剂疗效的潜在预测指标

Hurkmans, Daan P; Verdegaal, Els M E; Hogan, Sabrina A; de Wijn, Rik; Hovestad, Lies; van den Heuvel, Dianne M A; Ruijtenbeek, Rob; Welters, Marij J P; van Brakel, Mandy; Basak, Edwin A; Pinedo, Herbert M; Lamers, Cor H J; van de Werken, Harmen J G; Groten, John P; Debets, Reno; Levesque, Mitchell P; Dummer, Reinhard; Kapiteijn, Ellen; Mathijssen, Ron H J; Aerts, Joachim G J V; van der Burg, Sjoerd H

CD45RA(+)CCR7(-) CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab

在接受纳武利尤单抗治疗的非小细胞肺癌患者外周血中,缺乏共刺激受体的CD45RA(+)CCR7(-)CD8 T细胞的频率显著升高。

Kunert, Andre; Basak, Edwin A; Hurkmans, Daan P; Balcioglu, Hayri E; Klaver, Yarne; van Brakel, Mandy; Oostvogels, Astrid A M; Lamers, Cor H J; Bins, Sander; Koolen, Stijn L W; van der Veldt, Astrid A M; Sleijfer, Stefan; Mathijssen, Ron H J; Aerts, Joachim G J V; Debets, Reno

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody

利用与抗MAGE A1 TCR样单链抗体偶联的免疫脂质体靶向黑色素瘤

Saeed, Mesha; van Brakel, Mandy; Zalba, Sara; Schooten, Erik; Rens, Joost A P; Koning, Gerben A; Debets, Reno; Ten Hagen, Timo L M

TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets

TCR基因转移:MAGE-C2/HLA-A2和MAGE-A3/HLA-DP4表位作为黑色素瘤特异性免疫靶点

Straetemans, Trudy; van Brakel, Mandy; van Steenbergen, Sabine; Broertjes, Marieke; Drexhage, Joost; Hegmans, Joost; Lambrecht, Bart N; Lamers, Cor; van Der Bruggen, Pierre; Coulie, Pierre G; Debets, Reno